Ronald Van Eijk Email & Phone Number

Rotterdam

Leiden

For 25 years, molecular biologists have been working within Pathology to shape Molecular Pathology within diagnostics. They are united within the working group for Molecular Diagnostics in Pathology. One of the objectives of this working group is to define the role of molecular biologist within Pathology. This has led to the recognition of the Clinical Molecular Biologist in Pathology (KMBP) by the Dutch Association for Pathology (NVVP).The responsibilities of the KMBP are laid down in the Quality Guideline for Molecular Diagnostics in Pathology of the NNVP Committee on Molecular Diagnostics in Pathology on 28 June 2005 (revised version in 2014; http://www.pathology.nl/beroepsuitoefening/richtlijnen) . “The KMBP determines the molecular approach and is responsible for the choice of the underlying molecular technique, the quality and reliability of the execution of the analysis and for reporting the results to an internal or external (in the case of molecular consultation) pathologist so that these can be adequately integrated into the report to the treating physician. ”The required professional competencies and detailed responsibilities of the KMBP are described in the document 'Training Clinical Molecular Biologist in Pathology'. It also describes the definition of the specific responsibilities of the pathologist and the KMBP in molecular diagnostics. (Translated from Dutch https://www.umcg.nl/NL/UMCG/Afdelingen/Pathologie/Professionals/moleculaire-diagnostiek/klinisch-moleculair-bioloog-in-de-pathologie/Paginas/default.aspx#

Department Of Pathology

New technologies for molecular analysis in molecular tumor diagnostics and research are being developed and implemented to keep pace with the latest insights.Development and implementation of state of the art high throughput molecular technology. Intermediary between biologists and bio-informatics. Technology development and Software applications for Molecular BiologyMy work is focused on the development of new assays for mutational studies in DNA isolated from Formalin Fixed Paraffin Embedded (FFPE) tissue. After validation of the assays they will be readily implemented in Molecular Tumor Diagnostics. KeywordsPathology, Mutation and chromosomal aberration screening, MLPA, SNP arrays, High Resolution Melting assays, Hydrolysis Probes Assays, Sanger and Next Generation Sequencing.Laboratory Automation, Robotics and High Throughput Screening